Teranode Named "Cool Vendor" by Leading Analyst Firm
Vendor's Selection Based on how Innovative, Impactful, and Intriguing They Are
Vendor's Selection Based on how Innovative, Impactful, and Intriguing They Are
SEATTLE, Wash. April 4, 2005 -- Teranode Corporation, the leading innovator of experiment design automation (XDA) software for the Life Sciences industry, today announced it has been included in the list of "Cool Vendors" in the "Cool Vendors in Emerging Trends and Technologies," March 24, 2005 by Carol Rozwell, et al of Gartner, Inc.
Teranode was listed in the report which discusses how the future of technology in the Life Sciences is tied to the continued penetration of technology into new areas and the massive proliferation of connected devices.
Teranode's award-winning technology, TERANODE Design Suite (TDS), combines computational and experimental biology to automate tasks associated with planning, managing, and analyzing experiments. TERANODE Design Suite is a visual tool and platform that allows protocols and biological systems to be described, simulated, and automatically linked to create higher value physical experiments for the benefit of accelerated R&D.
"We're thrilled to have been recognized by Gartner," said Joseph Duncan, CEO of Teranode. "R&D organizations are more reliant on data than ever before and the Life Sciences industry is certainly no exception. Life Sciences is dependant on the experimental productivity of its labs from early-stage discovery through late-stage clinical trails. Our platform brings this community innovative new combination of experimental and computational biology to leverage data for the design and management of higher value experiments."
About Gartner's Cool Vendors Selection Process
Gartner's listing does not constitute an exhaustive list of vendors in any given technology area, but rather is designed to highlight interesting, new and innovative vendors, products, and services. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness of a particular purpose.
Gartner defines a cool vendor as a company that offers technologies or solutions that are: Innovative, enable users to do things they couldn't do before; Impactful, have, or will have, business impact (not just technology for the sake of technology); Intriguing, have caught Gartner's interest or curiosity in approximately the past six months.
About Teranode Corporatio
Teranode Corporation, headquartered in Seattle, WA, is the leading innovator of experiment design automation (XDA) software to improve the value of experiments for the benefit of accelerated R&D. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington. TERANODE Design Suite is being used by leading pharmaceutical, biotechnology, research, and academic organizations including Pfizer, AstraZeneca, and Fred Hutchinson Cancer Research Center.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
